Literature DB >> 28104292

Hepatic Prominin-1 expression is associated with biliary fibrosis.

Marie V Nguyen1, Jessica A Zagory1, William H Dietz1, Alex Park1, Michael Fenlon1, Menghan Zhao1, Jiabo Xu1, Ingrid Lua2, Nirmala Mavila3, Kinji Asahina2, Kasper S Wang4.   

Abstract

BACKGROUND: Intrahepatic biliary fibrosis, as seen with cholestatic liver injuries such as biliary atresia, is mechanistically distinct from fibrosis caused by hepatocyte toxicity. We previously demonstrated the expansion of cells expressing the stem/progenitor cell marker Prominin-1, within regions of developing fibrosis in biliary atresia. Thus, we hypothesized that Prominin-1 expression is biliary fibrosis-specific.
METHODS: Gene expression of Prominin-1 was analyzed in adult mice undergoing either cholestatic bile duct ligation or hepatotoxic carbon tetrachloride administration by quantitative polymerase chair reaction. Lineage tracing of Prominin-1-expressing cells and Collagen-1α-expressing cells was performed after bile duct ligation in Prominin-1cre-ert2-lacz;Gfplsl and Collagen-1αGfp transgenic mice, respectively.
RESULTS: Prominin-1 expression increased significantly after bile duct ligation compared with sham (6.6 ± 0.9-fold change at 2 weeks, P < .05) but not with carbon tetrachloride (-0.7 ± 0.5-fold change, not significant). Upregulation of Prominin-1 was observed histologically throughout the liver as early as 5 days after bile duct ligation in Prominin-1cre-ert2-lacz mice by LacZ staining in nonhepatocyte cells. Lineage tracing of Prominin-1-expressing cells labeled prior to bile duct ligation in Prominin-1cre-ert2-lacz;Gfplsl mice, demonstrated increasing colocalization of GREEN FLUORESCENT PROTEIN with biliary marker CYTOKERATIN-19 within ductular reactions up to 5 weeks after bile duct ligation consistent with biliary transdifferentiation. In contrast, rare colocalization of GREEN FLUORESCENT PROTEIN with mesenchymal marker α-SMOOTH MUSCLE ACTIN in Prominin-1cre-ert2-lacz;Gfplsl mice and some colocalization of GREEN FLUORESCENT PROTEIN with PROMININ-1 in Collagen-1αGfp mice, indicate minimal contribution of Prominin-1 progenitor cells to the pool of collagen-producing myofibroblasts.
CONCLUSION: During biliary fibrosis Prominin-1-expressing progenitor cells transdifferentiate into cells within ductular reactions. This transdifferentiation may promote fibrosis.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28104292      PMCID: PMC5404955          DOI: 10.1016/j.surg.2016.09.043

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  16 in total

1.  A CD133-expressing murine liver oval cell population with bilineage potential.

Authors:  C Bart Rountree; Lora Barsky; Shundi Ge; Judy Zhu; Shantha Senadheera; Gay M Crooks
Journal:  Stem Cells       Date:  2007-06-21       Impact factor: 6.277

2.  The anatomic pattern of biliary atresia identified at time of Kasai hepatoportoenterostomy and early postoperative clearance of jaundice are significant predictors of transplant-free survival.

Authors:  Riccardo Superina; John C Magee; Mary L Brandt; Patrick J Healey; Greg Tiao; Fred Ryckman; Frederick M Karrer; Kishore Iyer; Annie Fecteau; Karen West; R Cartland Burns; Alan Flake; Hanmin Lee; Jeff A Lowell; Pat Dillon; Paul Colombani; Richard Ricketts; Yun Li; Jeffrey Moore; Kasper S Wang
Journal:  Ann Surg       Date:  2011-10       Impact factor: 12.969

Review 3.  Recent advances in the pathogenesis and management of biliary atresia.

Authors:  Jessica A Zagory; Marie V Nguyen; Kasper S Wang
Journal:  Curr Opin Pediatr       Date:  2015-06       Impact factor: 2.856

Review 4.  The intriguing links between prominin-1 (CD133), cholesterol-based membrane microdomains, remodeling of apical plasma membrane protrusions, extracellular membrane particles, and (neuro)epithelial cell differentiation.

Authors:  Denis Corbeil; Anne-Marie Marzesco; Michaela Wilsch-Bräuninger; Wieland B Huttner
Journal:  FEBS Lett       Date:  2010-02-02       Impact factor: 4.124

5.  Fibroblast growth factor signaling regulates the expansion of A6-expressing hepatocytes in association with AKT-dependent β-catenin activation.

Authors:  Sarah Utley; David James; Nirmala Mavila; Marie V Nguyen; Christopher Vendryes; S Michael Salisbury; Jennifer Phan; Kasper S Wang
Journal:  J Hepatol       Date:  2013-12-21       Impact factor: 25.083

6.  Integrin alphavbeta6 and mediators of extracellular matrix deposition are up-regulated in experimental biliary atresia.

Authors:  Evan P Nadler; Danielle Patterson; Shelia Violette; Paul Weinreb; Michael Lewis; Margaret S Magid; M Alba Greco
Journal:  J Surg Res       Date:  2008-06-20       Impact factor: 2.192

7.  Characterization of hepatic stellate cells, portal fibroblasts, and mesothelial cells in normal and fibrotic livers.

Authors:  Ingrid Lua; Yuchang Li; Jessica A Zagory; Kasper S Wang; Samuel W French; Jean Sévigny; Kinji Asahina
Journal:  J Hepatol       Date:  2016-01-19       Impact factor: 25.083

8.  Origin of myofibroblasts in the fibrotic liver in mice.

Authors:  Keiko Iwaisako; Chunyan Jiang; Mingjun Zhang; Min Cong; Thomas Joseph Moore-Morris; Tae Jun Park; Xiao Liu; Jun Xu; Ping Wang; Yong-Han Paik; Fanli Meng; Masataka Asagiri; Lynne A Murray; Alan F Hofmann; Takashi Iida; Christopher K Glass; David A Brenner; Tatiana Kisseleva
Journal:  Proc Natl Acad Sci U S A       Date:  2014-07-29       Impact factor: 11.205

9.  Fibroblast growth factor receptor-mediated activation of AKT-β-catenin-CBP pathway regulates survival and proliferation of murine hepatoblasts and hepatic tumor initiating stem cells.

Authors:  Nirmala Mavila; David James; Sarah Utley; Nguyen Cu; Orly Coblens; Katrina Mak; C Bart Rountree; Michael Kahn; Kasper S Wang
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240

10.  Prominin 1 marks intestinal stem cells that are susceptible to neoplastic transformation.

Authors:  Liqin Zhu; Paul Gibson; D Spencer Currle; Yiai Tong; Robert J Richardson; Ildar T Bayazitov; Helen Poppleton; Stanislav Zakharenko; David W Ellison; Richard J Gilbertson
Journal:  Nature       Date:  2008-12-17       Impact factor: 49.962

View more
  7 in total

Review 1.  Adjuvant therapy in biliary atresia: hopelessly optimistic or potential for change?

Authors:  Mark Davenport
Journal:  Pediatr Surg Int       Date:  2017-09-22       Impact factor: 1.827

2.  Prominin-1 Promotes Biliary Fibrosis Associated With Biliary Atresia.

Authors:  Jessica A Zagory; Michael Fenlon; William Dietz; Menghan Zhao; Marie V Nguyen; Pavin Trinh; Maeva Adoumie; Alex Park; Jiabo Xu; Elaa Mahdi; Alison Glazier; Nicolas Malkoff; Nirmala Mavila; Kasper S Wang
Journal:  Hepatology       Date:  2019-04-11       Impact factor: 17.425

Review 3.  Newborn screening for biliary atresia in the United States.

Authors:  Cat Goodhue; Michael Fenlon; Kasper S Wang
Journal:  Pediatr Surg Int       Date:  2017-10-05       Impact factor: 1.827

4.  Prominin-1-Radixin axis controls hepatic gluconeogenesis by regulating PKA activity.

Authors:  Hyun Lee; Dong-Min Yu; Jun Sub Park; Hwayeon Lee; Jun-Seok Kim; Hong Lim Kim; Seung-Hoi Koo; Jae-Seon Lee; Sungsoo Lee; Young-Gyu Ko
Journal:  EMBO Rep       Date:  2020-10-08       Impact factor: 8.807

5.  Prominin-1-expressing hepatic progenitor cells induce fibrogenesis in murine cholestatic liver injury.

Authors:  Michael Fenlon; Celia Short; Jiabo Xu; Nicolas Malkoff; Elaa Mahdi; Michelle Hough; Alison Glazier; Calvin Lee; Kinji Asahina; Kasper S Wang
Journal:  Physiol Rep       Date:  2020-07

6.  Urea-based amino sugar agent clears murine liver and preserves protein fluorescence and lipophilic dyes.

Authors:  Michelle Hough; Michael Fenlon; Alison Glazier; Celia Short; Gerardo Esteban Fernandez; Jiabo Xu; Elaa Mahdi; Kinji Asahina; Kasper S Wang
Journal:  Biotechniques       Date:  2021-01-20       Impact factor: 1.993

7.  Hepatocyte-specific Prominin-1 protects against liver injury-induced fibrosis by stabilizing SMAD7.

Authors:  Hyun Lee; Dong-Min Yu; Myeong-Suk Bahn; Young-Jae Kwon; Min Jee Um; Seo Yeon Yoon; Ki-Tae Kim; Myoung-Woo Lee; Sung-Je Jo; Sungsoo Lee; Seung-Hoi Koo; Ki Hoon Jung; Jae-Seon Lee; Young-Gyu Ko
Journal:  Exp Mol Med       Date:  2022-08-29       Impact factor: 12.153

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.